Trials / Completed
CompletedNCT01240265
Vitamin D Supplementation in Breastfeeding Women
Maternal Oral Vitamin D Supplementation Via Daily or Monthly Regimens and the Effect on Levels of Vitamin D in Human Milk and Infant Serum
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 1 Month – 50 Years
- Healthy volunteers
- Accepted
Summary
Adequate vitamin D is essential for proper infant growth and development. However, human milk is low in vitamin D, and most infants do not receive recommended supplementation. Our aim is to assess the feasibility of providing adequate vitamin D to breastfed infants through maternal vitamin D supplementation. Forty non-pregnant, lactating women at least 18 years of age with exclusively breastfed infants between the ages of 1 and 6 months will be randomized to receive oral vitamin D as either 5,000 IU daily for 28 days or 150,000 IU as a single dose. Maternal serum calcium, phosphorus, vitamin D and 25(OH)D; maternal urinary calcium; maternal milk vitamin D and 25(OH)D will be measured on days 0, 1, 3, 7, 14, and 28 of the study; and infant serum vitamin D and 25(OH)D will be measured on days 0 and 28.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Vitamin D3 | 150,000 IU orally given once |
| DIETARY_SUPPLEMENT | Vitamin D3 | 5000 IU given orally daily for 28 days |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2011-08-01
- Completion
- 2011-08-01
- First posted
- 2010-11-15
- Last updated
- 2013-04-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01240265. Inclusion in this directory is not an endorsement.